Protein profile changes in platelet concentrates according to storage and leukoreduction - Analysis using proteomics technology

Korean Journal of Laboratory Medicine

Volumn 28, Issue 1, 2008, Pages 53-63

  Ryu, Sook Won ^a   Suh, In Bum ^a   Cho, Yoonjeong ^b  

^a Kangwon National University   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

2 DE; Filtration; MALDI TOF; PC; PMF; Protein profile; Storage; Supernatant

Indexed keywords

PROTEOME;

ARTICLE; BLOOD STORAGE; CHEMISTRY; HUMAN; LEUKAPHERESIS; MASS SPECTROMETRY; PROTEOMICS; THROMBOCYTE; THROMBOCYTE TRANSFUSION; TIME; TWO DIMENSIONAL GEL ELECTROPHORESIS;

BLOOD PLATELETS; BLOOD PRESERVATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; LEUKOCYTE REDUCTION PROCEDURES; PLATELET TRANSFUSION; PROTEOME; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TIME FACTORS;

EID: 58149117865     PISSN: 15986535     EISSN: None     Source Type: Journal    
DOI: 10.3343/kjlm.2008.28.1.53     Document Type: Article

References (31)

1. Heddle NM. Febrile nonhemolytic transfusion reactions to platelets. Curr Opin Hematol 1995;2:478-83.
2. Seghatchian J, Krailadsiri P, Dilger P, Thorpe R, Wadhwa M. Cytokines as quality indicators of leucoreduced red cell concentrates. Transfus Apher Sci 2002;26:43-6. (Pubitemid 34135395)
3. Boehlen F and Clemetson KJ. Platelet chemokines and their receptors: what is their relevance to platelet storage and transfusion practice? Transfus Med 2001;11:403-17. (Pubitemid 34044850)
4. Muylle L and Peetermans ME. Effect of prestorage leukocyte removal on the cytokine levels in stored platelet concentrates. Vox Sang 1994;66:14-7. (Pubitemid 24017151)
5. Yazer MH, Podlosky L, Clarke G, Nahirniak SM. The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC. Transfusion 2004; 44:10-5. (Pubitemid 38177130)
6. Paglino JC, Pomper GJ, Fisch GS, Champion MH, Snyder EL. Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction. Transfusion 2004;44:16-24. (Pubitemid 38177131)
7. Kluter H, Bubel S, Kirchner H, Wilhelm D. Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations. Transfusion 1999;39:1179-84.
8. Miletic VD and Popovic O. Complement activation in stored platelet concentrates. Transfusion 1993;33:150-4. (Pubitemid 23060548)
9. Silliman CC, Johnson CA, Clay KL, Thurman GW, Ambruso DR. Compounds biologically similar to platelet activating factor are present in stored blood components. Lipids 1993;28:415-8. (Pubitemid 23143823)
10. Heddle NM, Klama L, Singer J, Richards C, Fedak P, Walker I, et al. The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994;331:625-8. (Pubitemid 24276861)
11. Muylle L, Joos M, Wouters E, De Bock R, Peetermans ME. Increased tumor necrosis factor alpha (TNF alpha), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNF alpha and IL-6 levels and febrile transfusion reactions. Transfusion 1993;33:195-9. (Pubitemid 23073640)
12. Seghatchian J. The platelet storage lesion: A comparative analysis of six leukoreduction processes in terms of biocompatability, microvesiculation, retention of prions, and generation/removal of biological response modifiers. Transfus Apher Sci 2005;15:[Epub ahead of print].
13. Zhou M, Conrads TP, Veenstra TD. Proteomics approaches to biomarker detection. Brief Funct Genomic Proteomic 2005;4:69-75. (Pubitemid 40724169)
14. Omenn GS, States DJ, Adamski M, Blackwell TW, Menon R, Hermjakob H, et al. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 2005;5:3226-45. (Pubitemid 41192032)
15. Reddy KS and Perrotta PL. Proteomics in transfusion medicine. Transfusion 2004;44:601-4. (Pubitemid 38437598)
16. Sarkodee-Adoo CB, Kendall JM, Sridhara R, Lee EJ, Schiffer CA. The relationship between the duration of platelet storage and the development of transfusion reactions. Transfusion 1998;38:229-35. (Pubitemid 28180640)
17. Omenn GS. The Human Proteome Organization Plasma Proteome Project pilot phase: reference specimens, technology platform comparisons, and standardized data submissions and analyses. Proteomics 2004;4:1235-40. (Pubitemid 38648012)
18. O Neill EE, Brock CJ, von Kriegsheim AF, Pearce AC, Dwek RA, Watson SP, et al. Towards complete analysis of the platelet proteome. Proteomics 2002;2:288-305. (Pubitemid 34269983)
19. Garcia A, Zitzmann N, Watson SP. Analyzing the platelet proteome. Semin Thromb Hemost 2004;30:485-9. (Pubitemid 39180723)
20. Kakhniashvili DG, Bulla LA Jr, Goodman SR. The human erythrocyte proteome: analysis by ion trap mass spectrometry. Mol Cell Proteomics 2004;3:501-9. (Pubitemid 38714291)
21. Anderson NL, Polanski M, Pieper R, Gatlin T, Tirumalai RS, Conrads TP, et al. The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol Cell Proteomics 2004;3:311-26.
22. Anniss AM, Glenister KM, Killian JJ, Sparrow RL. Proteomic analysis of supernatants of stored red blood cell products. Transfusion 2005;45:1426-33. (Pubitemid 44194645)
23. Thiele T, Steil L, Gebhard S, Scharf C, Hammer E, Brigulla M, et al. Profiling of alterations in platelet proteins during storage of platelet concentrates. Transfusion 2007;47:1221-33. (Pubitemid 46934314)
24. Ledent E and Berlin G. Factors influencing white cell removal from red cell concentrates by filtration. Transfusion 1996;36:714-8. (Pubitemid 26320078)
25. Aye MT, Palmer DS, Giulivi A, Hashemi S. Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors. Transfusion 1995;35:117-24.
26. Wolpe SD, Sherry B, Juers D, Davatelis G, Yurt RW, Cerami A. Identification and characterization of macrophage inflammatory protein 2. Proc Natl Acad Sci USA 1989;86:612-6. (Pubitemid 19037791)
27. King AG, Johanson K, Frey CL, DeMarsh PL, White JR, McDevitt P, et al. Identification of unique truncated KC/GRO beta chemokines with potent hematopoietic and anti-infective activities. J Immunol 2000;164:3774-82. (Pubitemid 30169834)
28. Driscoll KE. TNFalpha and MIP-2: role in particle-induced inflammation and regulation by oxidative stress. Toxicol Lett 2000;112-113:177-83. (Pubitemid 30138121)
29. Fishley B and Alexander WS. Thrombopoietin signalling in physiology and disease. Growth Factors 2004;22:151-5. (Pubitemid 39377907)
30. Xie MH, Aggarwal S, Ho WH, Foster J, Zhang Z, Stinson J, et al. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J Biol Chem 2000;275:31335-9.
31. Boniface K, Bernard FX, Garcia M, Gurney AL, Lecron JC, Morel F. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol 2005;174:3695-702. (Pubitemid 40354080)